Joseph Pantginis
Stock Analyst at HC Wainwright & Co.
(1.19)
# 3,427
Out of 4,827 analysts
786
Total ratings
29.53%
Success rate
-14.98%
Average return
Main Sectors:
Stocks Rated by Joseph Pantginis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KRYS Krystal Biotech | Reiterates: Buy | $240 | $136.80 | +75.44% | 30 | May 6, 2025 | |
| BMEA Biomea Fusion | Maintains: Buy | $40 → $18 | $1.70 | +958.82% | 30 | May 6, 2025 | |
| CLDX Celldex Therapeutics | Reiterates: Buy | $80 | $18.91 | +323.06% | 32 | May 6, 2025 | |
| NVCT Nuvectis Pharma | Reiterates: Buy | $11 → $15 | $8.79 | +70.65% | 9 | Apr 30, 2025 | |
| KURA Kura Oncology | Reiterates: Buy | $40 | $5.68 | +604.23% | 26 | Apr 28, 2025 | |
| ATNM Actinium Pharmaceuticals | Reiterates: Buy | $4 | $1.39 | +187.77% | 29 | Apr 28, 2025 | |
| VYNE VYNE Therapeutics | Maintains: Buy | $5.75 → $4.5 | $1.37 | +228.47% | 22 | Apr 25, 2025 | |
| TNYA Tenaya Therapeutics | Reiterates: Buy | $5 | $0.45 | +1,011.36% | 16 | Apr 25, 2025 | |
| ESPR Esperion Therapeutics | Reiterates: Buy | $16 | $0.87 | +1,737.18% | 28 | Apr 25, 2025 | |
| VKTX Viking Therapeutics | Reiterates: Buy | $102 | $27.56 | +270.10% | 32 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $24 | $1.76 | +1,263.64% | 18 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $120 | $33.04 | +263.20% | 48 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.79 | +458.66% | 2 | Apr 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $16 | $6.42 | +149.22% | 19 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $3.14 | - | 9 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $31 | $2.55 | +1,115.69% | 31 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $21 | $0.56 | +3,619.45% | 14 | Apr 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $0.80 | +1,400.00% | 1 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $2.03 | +688.18% | 11 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $26 | $3.16 | +722.78% | 12 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $0.69 | +483.94% | 21 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $104 | $24.48 | +324.84% | 23 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $13 | $1.16 | +1,020.69% | 30 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $0.87 | - | 18 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $37 | $9.00 | +311.11% | 17 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $77 | $6.89 | +1,017.56% | 21 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $1.53 | +618.95% | 7 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.33 | +2,967.48% | 2 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $35 | $3.16 | +1,007.59% | 7 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $4.39 | +264.88% | 19 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $4.1 | $4.15 | -1.20% | 18 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $0.44 | +1,961.38% | 11 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $57 | $18.47 | +208.61% | 26 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $32 | $3.13 | +922.36% | 27 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $21 | $4.93 | +325.70% | 1 | Feb 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $1.68 | +1,090.48% | 14 | Jan 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $1.38 | +407.25% | 14 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $2.65 | +843.40% | 16 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $2.30 | +552.17% | 16 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $105.62 | - | 20 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $26 | $1.72 | +1,411.63% | 3 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $32 | $16.28 | +96.62% | 5 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.88 | +379.08% | 3 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $4.08 | +512.94% | 4 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $1.14 | +8,671.93% | 7 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.70 | - | 6 | Dec 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $32 | $1.74 | +1,744.38% | 4 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $30 | $2.62 | +1,045.04% | 2 | Nov 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.97 | - | 2 | Jan 31, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $18 → $33 | $34.85 | -5.31% | 2 | Nov 14, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 → $78 | $6.69 | +1,065.92% | 1 | Mar 24, 2017 |
Krystal Biotech
May 6, 2025
Reiterates: Buy
Price Target: $240
Current: $136.80
Upside: +75.44%
Biomea Fusion
May 6, 2025
Maintains: Buy
Price Target: $40 → $18
Current: $1.70
Upside: +958.82%
Celldex Therapeutics
May 6, 2025
Reiterates: Buy
Price Target: $80
Current: $18.91
Upside: +323.06%
Nuvectis Pharma
Apr 30, 2025
Reiterates: Buy
Price Target: $11 → $15
Current: $8.79
Upside: +70.65%
Kura Oncology
Apr 28, 2025
Reiterates: Buy
Price Target: $40
Current: $5.68
Upside: +604.23%
Actinium Pharmaceuticals
Apr 28, 2025
Reiterates: Buy
Price Target: $4
Current: $1.39
Upside: +187.77%
VYNE Therapeutics
Apr 25, 2025
Maintains: Buy
Price Target: $5.75 → $4.5
Current: $1.37
Upside: +228.47%
Tenaya Therapeutics
Apr 25, 2025
Reiterates: Buy
Price Target: $5
Current: $0.45
Upside: +1,011.36%
Esperion Therapeutics
Apr 25, 2025
Reiterates: Buy
Price Target: $16
Current: $0.87
Upside: +1,737.18%
Viking Therapeutics
Apr 24, 2025
Reiterates: Buy
Price Target: $102
Current: $27.56
Upside: +270.10%
Apr 21, 2025
Reiterates: Buy
Price Target: $24
Current: $1.76
Upside: +1,263.64%
Apr 21, 2025
Reiterates: Buy
Price Target: $120
Current: $33.04
Upside: +263.20%
Apr 14, 2025
Reiterates: Buy
Price Target: $10
Current: $1.79
Upside: +458.66%
Apr 10, 2025
Downgrades: Neutral
Price Target: $16
Current: $6.42
Upside: +149.22%
Apr 9, 2025
Reiterates: Neutral
Price Target: n/a
Current: $3.14
Upside: -
Apr 8, 2025
Reiterates: Buy
Price Target: $31
Current: $2.55
Upside: +1,115.69%
Apr 4, 2025
Reiterates: Buy
Price Target: $21
Current: $0.56
Upside: +3,619.45%
Apr 3, 2025
Initiates: Buy
Price Target: $12
Current: $0.80
Upside: +1,400.00%
Apr 1, 2025
Reiterates: Buy
Price Target: $16
Current: $2.03
Upside: +688.18%
Mar 31, 2025
Maintains: Buy
Price Target: $9 → $26
Current: $3.16
Upside: +722.78%
Mar 28, 2025
Reiterates: Buy
Price Target: $4
Current: $0.69
Upside: +483.94%
Mar 28, 2025
Reiterates: Buy
Price Target: $104
Current: $24.48
Upside: +324.84%
Mar 27, 2025
Maintains: Buy
Price Target: $21 → $13
Current: $1.16
Upside: +1,020.69%
Mar 27, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.87
Upside: -
Mar 21, 2025
Reiterates: Buy
Price Target: $37
Current: $9.00
Upside: +311.11%
Mar 20, 2025
Reiterates: Buy
Price Target: $77
Current: $6.89
Upside: +1,017.56%
Mar 19, 2025
Reiterates: Buy
Price Target: $11
Current: $1.53
Upside: +618.95%
Mar 18, 2025
Reiterates: Buy
Price Target: $10
Current: $0.33
Upside: +2,967.48%
Mar 14, 2025
Reiterates: Buy
Price Target: $35
Current: $3.16
Upside: +1,007.59%
Mar 11, 2025
Reiterates: Buy
Price Target: $16
Current: $4.39
Upside: +264.88%
Mar 11, 2025
Downgrades: Neutral
Price Target: $4.1
Current: $4.15
Upside: -1.20%
Mar 11, 2025
Reiterates: Buy
Price Target: $9
Current: $0.44
Upside: +1,961.38%
Mar 5, 2025
Reiterates: Buy
Price Target: $57
Current: $18.47
Upside: +208.61%
Feb 28, 2025
Reiterates: Buy
Price Target: $32
Current: $3.13
Upside: +922.36%
Feb 4, 2025
Maintains: Buy
Price Target: $8 → $21
Current: $4.93
Upside: +325.70%
Jan 15, 2025
Reiterates: Buy
Price Target: $20
Current: $1.68
Upside: +1,090.48%
Dec 19, 2024
Reiterates: Buy
Price Target: $7
Current: $1.38
Upside: +407.25%
Dec 18, 2024
Reiterates: Buy
Price Target: $25
Current: $2.65
Upside: +843.40%
Dec 11, 2024
Reiterates: Buy
Price Target: $15
Current: $2.30
Upside: +552.17%
Dec 11, 2024
Reiterates: Buy
Price Target: n/a
Current: $105.62
Upside: -
Nov 18, 2024
Maintains: Buy
Price Target: $24 → $26
Current: $1.72
Upside: +1,411.63%
Nov 11, 2024
Maintains: Buy
Price Target: $3 → $32
Current: $16.28
Upside: +96.62%
Nov 11, 2024
Reiterates: Buy
Price Target: $9
Current: $1.88
Upside: +379.08%
Oct 2, 2024
Reiterates: Buy
Price Target: $25
Current: $4.08
Upside: +512.94%
May 16, 2024
Reiterates: Buy
Price Target: $100
Current: $1.14
Upside: +8,671.93%
Dec 1, 2021
Downgrades: Neutral
Price Target: n/a
Current: $1.70
Upside: -
Feb 25, 2021
Maintains: Buy
Price Target: $36 → $32
Current: $1.74
Upside: +1,744.38%
Nov 3, 2020
Upgrades: Buy
Price Target: $30
Current: $2.62
Upside: +1,045.04%
Jan 31, 2018
Downgrades: Neutral
Price Target: n/a
Current: $1.97
Upside: -
Nov 14, 2017
Assumes: Buy
Price Target: $18 → $33
Current: $34.85
Upside: -5.31%
Mar 24, 2017
Reiterates: Buy
Price Target: $60 → $78
Current: $6.69
Upside: +1,065.92%